News
According to BIS Research, Antibody Conjugate Oligonucleotides (ACOs) combine the gene-modulating properties of ...
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...
Developed by ALX Oncology's protein engineers utilizing the Company's proprietary topoisomerase I inhibitor payload and ...
Its ability to measure neutralising antibodies can help determine the efficacy of new vaccines. Read more at straitstimes.com ...
This two-step process is designed to guide the immune response further along the path toward bnAb development by generating VRC01-class antibodies -- early immune defenses with key features of bnAbs.
Pharmacokinetic and safety data from healthy volunteers anticipated around YE 2025 On track to initiate a Phase 2 study in 1H 2026 ORKA-002 preclinical data demonstrate the potential for dosing two to ...
18don MSN
Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and exits the cell. Until recently, scientists believed antibodies couldn't ...
B-cell maturation antigen (BCMA)-directed bispecific antibodies have tolerable safety profiles in frail patients with relapsed/refractory multiple myeloma (MM), according to a real-world study ...
SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Bio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced a licensing agreement with AstralBio Inc. for a ...
Multiple HCPs have requested from Invivyd a monoclonal antibody (mAb) for treatment of active measles infection and post-exposure prophylaxis to reduce the consequence of outbreaks. Such a medicine co ...
Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.
5d
News-Medical.Net on MSNHIV vaccine study marks breakthrough in targeting broad immune responsesA decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results